DRMAW
Dermata Therapeutics Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-2.16
Beta
0.67
52W High
$0.03
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Dermata Therapeutics Inc. Warrant
Dermata Therapeutics Inc. is a forward-thinking biotechnology company focused on developing cutting-edge therapies for dermatological conditions, particularly those with high unmet medical needs such as acne. Utilizing its proprietary technology platform, Dermata is advancing a diverse pipeline of product candidates poised to meet the increasing demand for effective skin disorder treatments. With a strategic emphasis on innovation and a growing presence in the biotechnology sector, Dermata presents a compelling opportunity for institutional investors aiming to support impactful healthcare advancements.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-4.09M |
| Operating Margin | 0.00% |
| Return on Equity | -103.60% |
| Return on Assets | -52.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.59 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $3.17M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
170.51%
HV 20-Day
138.88%
HV 30-Day
129.88%
HV 60-Day
164.43%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/25/2026